COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study

por Bhatt, Neel S., Sharma, Akshay, St. Martin, Andrew, Martens, Michael, Riches, Marcie L., Dandoy, Christopher E, Auletta, Jeffery J.
Publicado 2021

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

por Frigault, Matthew J., Nikiforow, Sarah, Mansour, Michael K., Hu, Zhen-Huan, Horowitz, Mary M., Riches, Marcie L., Hematti, Peiman, Turtle, Cameron J., Zhang, Mei-Jie, Perales, Miguel-Angel, Pasquini, Marcelo C.
Publicado 2020

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis

por Riches, Marcie L., Trifilio, Steven, Chen, Min, Ahn, Kwang Woo, Langston, Amelia, Lazarus, Hillard M., Marks, David I., Martino, Rodrigo, Maziarz, Richard T., Papinicolou, Genofeva A., Wingard, John R., Young, Jo-Anne H., Bennett, Charles L.
Publicado 2015

Incidence and Impact of Community Respiratory Viral Infection (CRV) in Haploidentical and Matched Sibling Donors Receiving Post-Transplant Cyclophosphamide (PTCy): A CIBMTR Analysi...

por Taplitz, Randy, Maziarz, Richard T., Mulroney, Carolyn, Perales, Miguel, Romee, Rizwan, Goldsmith, Scott R., Fuchs, Ephraim J., Bashey, Asad, Ciurea, Stefan O., Singh, Anurag K, Ganguly, Siddhartha, Kim, Soyoung, Chen, Min, Chemaly, Roy F., Komanduri, Krishna V., Riches, Marcie L.
Publicado 2020

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

por Sharma, Akshay, Bhatt, Neel S, St Martin, Andrew, Abid, Muhammad Bilal, Bloomquist, Jenni, Chemaly, Roy F, Dandoy, Christopher, Gauthier, Jordan, Gowda, Lohith, Perales, Miguel-Angel, Seropian, Stuart, Shaw, Bronwen E, Tuschl, Eileen E, Zeidan, Amer M, Riches, Marcie L, Shah, Gunjan L
Publicado 2021

COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study

por Sharma, Akshay, Bhatt, Neel S., Martin, Andrew St., Abid, Muhammad Bilal, Bloomquist, Jenni, Chemaly, Roy F., Dandoy, Christopher E., Gauthier, Jordan, Gowda, Lohith, Perales, Miguel A., Seropian, Stuart E., Shaw, Bronwen E., Tuschl, Eileen E., Zeidan, Amer, Riches, Marcie L., Shah, Gunjan L.
Publicado 2021

Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

por Riches, Marcie L., Hill, Joshua A., Martens, Michael, Auletta, Jeffery James, Baluch, Aliyah, Bhavsar, Kavita, Brown, Janice (Wes), Dhodapkar, Madhav Vishnu, DiFronzo, Nancy, Howard, Alan, Ibrahim, Uroosa, Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Sharon, Elad, Spahn, Ashley, Toor, Amir A., Waldvogel, Stephanie, Westervelt, Peter, Young, Jo-Anne H., Perales, Miguel-Angel, Horowitz, Mary M.
Publicado 2022

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoieti...

por Dandoy, Christopher E., Kim, Soyoung, Chen, Min, Ahn, Kwang Woo, Ardura, Monica I., Brown, Valerie, Chhabra, Saurabh, Diaz, Miguel Angel, Dvorak, Christopher, Farhadfar, Nosha, Flagg, Aron, Ganguly, Siddartha, Hale, Gregory A., Hashmi, Shahrukh K., Hematti, Peiman, Martino, Rodrigo, Nishihori, Taiga, Nusrat, Roomi, Olsson, Richard F., Rotz, Seth J., Sung, Anthony D., Perales, Miguel-Angel, Lindemans, Caroline A., Komanduri, Krishna V., Riches, Marcie L.
Publicado 2020

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients

por Zhu, Jing, Patel, Tejendra, Miller, Jordan A., Torrice, Chad D., Aggarwal, Mehak, Sketch, Margaret R., Alexander, Maurice D., Armistead, Paul M., Coghill, James M., Grgic, Tatjana, Jamieson, Katarzyna J., Ptachcinski, Jonathan R., Riches, Marcie L., Serody, Jonathan S., Schmitz, John L., Shaw, J. Ryan, Shea, Thomas C., Suzuki, Oscar, Vincent, Benjamin G., Wood, William A., Rao, Kamakshi V., Wiltshire, Tim, Weimer, Eric T., Crona, Daniel J.
Publicado 2020

Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study

por Bhatt, Neel S., Sharma, Akshay, St. Martin, Andrew, Abid, Muhammad Bilal, Brown, Valerie I., Diaz Perez, Miguel Angel, Frangoul, Haydar, Gadalla, Shahinaz M., Herr, Megan M., Krem, Maxwell M., Lazarus, Hillard M., Martens, Michael J., Mehta, Parinda A., Nishihori, Taiga, Prestidge, Tim, Pulsipher, Michael A., Rangarajan, Hemalatha G., Williams, Kirsten M., Winestone, Lena E., Yin, Dwight E., Riches, Marcie L., Dandoy, Christopher E., Auletta, Jeffery J.
Publicado 2022

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

por Hill, Joshua A., Martens, Michael J., Young, Jo-Anne H., Bhavsar, Kavita, Kou, Jianqun, Chen, Min, Lee, Lik Wee, Baluch, Aliyah, Dhodapkar, Madhav V., Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Armistead, Paul, Westervelt, Peter, McCarty, John, McGuirk, Joseph, Hamadani, Mehdi, DeWolf, Susan, Hosszu, Kinga, Sharon, Elad, Spahn, Ashley, Toor, Amir A., Waldvogel, Stephanie, Greenberger, Lee M., Auletta, Jeffery J., Horowitz, Mary M., Riches, Marcie L., Perales, Miguel-Angel
Publicado 2023

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR(®) study

por Maziarz, Richard T., Brazauskas, Ruta, Chen, Min, McLeod, Aleksandra A., Martino, Rodrigo, Wingard, John R., Aljurf, Mahmoud, Battiwalla, Minoo, Dvorak, Christopher C., George, Biju, Guinan, Eva C., Hale, Gregory A., Lazarus, Hillard M., Lee, Jong-Wook, Liesveld, Jane L., Ramanathan, Muthalagu, Reddy, Vijay, Savani, Bipin N., Smith, Franklin O., Strasfeld, Lynne, Taplitz, Randy A., Ustun, Celalettin, Boeckh, Michael J., Gea-Banacloche, Juan, Lindemans, Caroline A., Auletta, Jeffery J., Riches, Marcie L.
Publicado 2016

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors

por Pulsipher, Michael A., Logan, Brent R., Kiefer, Deidre M., Chitphakdithai, Pintip, Riches, Marcie L., Rizzo, J. Douglas, Anderlini, Paolo, Leitman, O’Susan F., Kobusingye, Hati, Besser, RaeAnne M., Miller, John P., Drexler, Rebecca J., Abdel-Mageed, Aly, Ahmed, Ibrahim A., Akard, Luke P., Artz, Andrew S., Ball, Edward D., Bayer, Ruthee-Lu, Bigelow, Carolyn, Bolwell, Brian J., Broun, E. Randolph, Delgado, David C., Duckworth, Katharine, Dvorak, Christopher C., Hahn, Theresa E., Haight, Ann E., Hari, Parameswaran N., Hayes-Lattin, Brandon M., Jacobsohn, David A., Jakubowski, Ann A., Kasow, Kimberly A., Lazarus, Hillard M., Liesveld, Jane L., Linenberger, Michael, Litzow, Mark R., Longo, Walter, Magalhaes-Silverman, Margarida, McCarty, John M., McGuirk, Joseph P., Mori, Shahram, Parameswaran, Vinod, Prasad, Vinod K., Rowley, Scott D., Rybka, Witold B., Sahdev, Indira, Schriber, Jeffrey R., Selby, George B., Shaughnessy, Paul J., Shenoy, Shalini, Spitzer, Thomas, Tse, William T., Uberti, Joseph P., Vusirikala, Madhuri, Waller, Edmund K., Weisdorf, Daniel J., Yanik, Gregory A., Navarro, Willis H., Horowitz, Mary M., Switzer, Galen E., Confer, Dennis L., Shaw, Bronwen E.
Publicado 2019